Hittnau, Switzerland

Peter Bruenker

USPTO Granted Patents = 35 

 

 

Average Co-Inventor Count = 7.6

ph-index = 13

Forward Citations = 554(Granted Patents)


Location History:

  • Schlieren, CH (2020 - 2022)
  • Hittnau, CH (2013 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
35 patents (USPTO):

Title: The Innovative Contributions of Peter Bruenker in Biotech

Introduction

Peter Bruenker, based in Hittnau, Switzerland, is a prolific inventor and a significant contributor to the field of biotechnology, holding an impressive total of 33 patents. His work primarily focuses on the development of novel bispecific antibodies and antigen binding molecules, which have potential applications in immunotherapy.

Latest Patents

Among his latest patents is the invention of bispecific antibodies specific for OX40. This invention pertains to unique bispecific antigen binding molecules that consist of two main components: one moiety that binds to a target cell antigen and another that binds to a costimulatory TNF receptor family member. This invention also includes a Fc domain made up of first and second subunits that can stabilize the association of these molecules. Additionally, Bruenker has developed a patent for antigen binding molecules that comprise a trimeric TNF family ligand along with encoding polynucleotides. This innovative approach involves incorporating at least one moiety for binding a target cell antigen, a polypeptide with three ectodomains of a TNF ligand family member linked by peptide linkers, and a stabilizing Fc domain.

Career Highlights

Throughout his career, Peter Bruenker has made valuable contributions while working with leading pharmaceutical companies, including Roche Glycart AG and Hoffmann-La Roche Inc. His work in these esteemed organizations has allowed him to push the boundaries of biotechnological innovations.

Collaborations

Peter Bruenker has collaborated with notable peers in the industry, including Christian Klein and Pablo Umana. These collaborations have enriched his work and brought diverse expertise into the development of his innovative products.

Conclusion

Peter Bruenker continues to push the envelope in biotechnology through his inventive spirit and commitment to developing groundbreaking solutions. His significant portfolio of patents not only showcases his dedication to research and development but also his contributions to enhancing therapeutic strategies in precision medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…